- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antibody and antigen (Recombinant protein)
Diagnostic Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antibodies (anti-Cytokeratin 19 fragment antigen 21-1, anti-CYFRA21-1) and antigens (recombinant Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) protein) for Cancer CYFRA21-1 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-CYFRA21-1-Ag01 | Recombinant human KRT19/CYFRA21-1 Protein | 3090 |
| GMP-h-CYFRA21-1-Ab01 | Anti-human KRT19/CYFRA21-1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CYFRA21-1-Ab02 | Anti-human KRT19/CYFRA21-1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CYFRA21-1-Ab03 | Anti-human KRT19/CYFRA21-1 human monoclonal antibody (mAb) | 1953 |
| GMP-h-CYFRA21-1-Ab04 | Anti-human KRT19/CYFRA21-1 human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-CYFRA21-1-Ag01 |
| Product Name | Recombinant human KRT19/CYFRA21-1 Protein |
| Target/Biomarker | Cytokeratin 19 fragment antigen 21-1(CYFRA21-1) |
| Alias of Target/Biomarker | CK19, K19, K1CS |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CYFRA21-1 level test of Cancer (bronchopulmonary dysplasia) and related syndrome evaluation. |
| Products description | Recombinant human KRT19/CYFRA21-1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CYFRA21-1-Ab01, GMP-h-CYFRA21-1-Ab02 |
| Product Name | Anti-human KRT19/CYFRA21-1 mouse monoclonal antibody (mAb) |
| Target/Biomarker | Cytokeratin 19 fragment antigen 21-1(CYFRA21-1) |
| Alias of Target/Biomarker | CK19, K19, K1CS |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antibodies in CYFRA21-1 level test of Cancer (bronchopulmonary dysplasia) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human KRT19/CYFRA21-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CYFRA21-1-Ab03, GMP-h-CYFRA21-1-Ab04 |
| Product Name | Anti-human KRT19/CYFRA21-1 human monoclonal antibody (mAb) |
| Target/Biomarker | Cytokeratin 19 fragment antigen 21-1(CYFRA21-1) |
| Alias of Target/Biomarker | CK19, K19, K1CS |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) antibodies in CYFRA21-1 level test of Cancer (bronchopulmonary dysplasia) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human KRT19/CYFRA21-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
CYRFA 21-1 (cytokeratin 19 fragment) has been demonstrated as clinically useful in the prognostication and monitoring of non-small cell lung cancer (NSCLC). Elevated pretreatment levels may be associated with unfavorable prognosis, and decreasing levels during therapy predict an objective response to treatment. CYFRA 21
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments